A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 1)
Clinical trial NCT04575467 · COMPLETED
Trial details
- NCT number
- NCT04575467
- Sponsor
- Caliway Biopharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-09
- Primary completion
- 2021-11-15
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.